Company Filing History:
2 out of 512 
2 out of 560 
1 out of 504 
Years Active: 2016-2021
Title: Innovations of Guangli Yang in Proliferative Disease Treatment
Introduction
Guangli Yang is a notable inventor based in Syosset, NY, who has made significant contributions to the field of medicine through his innovative patents. With a total of four patents to his name, Yang's work primarily focuses on the treatment of proliferative diseases, including cancers and autoimmune disorders. His research has the potential to impact the lives of many patients suffering from these conditions.
Latest Patents
One of Guangli Yang's latest patents is titled "Phenylsulfonamido-benzofuran derivatives and uses thereof in the treatment of proliferative diseases." This patent describes phenylsulfonamido-benzofuran derivatives and their pharmaceutically acceptable salts. The patent also outlines pharmaceutical compositions, methods, uses, and kits involving specific compounds for treating and preventing proliferative diseases. These compounds are designed to inhibit at least one protein of the BCL-2 family, which plays a crucial role in the development of various proliferative diseases. Notably, some of these compounds are selective inhibitors of MCL-1, a member of the BCL-2 family.
Career Highlights
Throughout his career, Guangli Yang has worked with prestigious institutions such as the Sloan Kettering Institute for Cancer Research and the Memorial Sloan Kettering Cancer Center. His experience in these renowned organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Guangli Yang's notable coworkers include Ouathek Ouerfelli and Samuel J. Danishefsky. Their collaborative efforts have further advanced the research and development of innovative treatments for proliferative diseases.
Conclusion
Guangli Yang's contributions to the field of medicine through his patents and collaborations highlight his dedication to improving treatment options for patients with proliferative diseases. His innovative work continues to pave the way for future advancements in medical research and therapy.